Pharmaceutical Companies Given 30 Days Extension for Ceiling Price Relabelling
The Department of Pharmaceutical has extended the period of exemption in respect of ceiling price notification dated 14.06.2013 issued by the National Pharmaceutical Pricing Authority for a period of 30 days from 29.07.2013. Similarly, in respect of ceiling price notifications dated 21.06.2013, 28.06.2013 and 05.07.2013 issued by the NPPA, the period of validity of exemption is extended for a period not exceeding 30 days from the date when the period of 45 days will expire as granted by the Department of Revenue.
The aforesaid extension of exemption shall be applicable only for the purpose of exemption from the provisions of Central Excise Act regarding whole of the duty of excise leviable in case of re-printing, re-labelling, re-packing or stickering, in a premises which is not registered under the Central Excise Act, 1944 (1 of 1944) or the rules made thereunder.
In a circular issued today, the Department of Pharmaceutical exempted the scheduled formulations as defined under the Drugs Price Control Order (DPCO), 2013 published vide S.O. 1221 (E) dated the 15th May, 2013, falling under Chapter 30 of the First Schedule to the Central Excise Tariff Act, 1985 (5 of 1986) and which are subjected to re-printing, re-labeling, re-packing or stickering, in a premises which is not registered under the Central Excise Act, 1944 (1 of 1944) or the rules made thereunder, in pursuance of the provisions contained in the said Drugs Price Control Order (DPCO), 2013 from whole of the duty of excise leviable thereon under the said Central Excise Act subject to the conditions as stipulated therein.